JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99757

Mouse monoclonal [JDC-10] Anti-Human IgG Fc

Mouse monoclonal [JDC-10] Anti-Human IgG Fc

Be the first to review this product! Submit a review

|

(12 Publications)

Mouse monoclonal Anti-Human IgG Fc is an unconjugated secondary antibody that is suitable for Western blot, IHC, ICC/IF, ELISA, ICC and more.

- Reacts with the Fc portion of the heavy chain of all subclasses of Human IgG

別名を表示する

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

関連する標識済み抗体及び組成の異なる製品 (3)

  • Alkaline Phosphatase

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc (Alkaline Phosphatase)

  • HRP

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc (HRP)

  • 578 PE

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc (PE)

Key facts

宿主種

Mouse

ターゲット種

Human

ターゲットアイソタイプ

IgG

ターゲット特異性

Fc region

最小限の交差反応性
血清吸着処理済み

No

アプリケーション

ICC, ICC/IF, ELISA, Dot, IHC-Fr, WB

applications

クローン性

Monoclonal

クローン番号

JDC-10

アイソタイプ

IgG1

軽鎖のタイプ

kappa

免疫原

Native Full Length Protein corresponding to Human IGHG1.

P01857

特異性

<p>ab99757 reacts with the Fc portion of the heavy chain of all subclasses of Human IgG as demonstrated by ELISA; may also react with IgG from other species.</p>

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1 µg for 10^6 Cells", "notes":"<p>for indirect immunofluorescent staining of IgG+ Human B lymphocytes.</p>" }, "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

This antibody reacts with the Fc region of Human IgG.

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

The immunogen is purified human IgG1 myeloma protein.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein G
バッファー組成
pH: 8.2 Constituents: 100% Borate buffered saline
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

製品プロトコール

ターゲットの情報

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

追加のターゲット

IGHG3,IGHG2,IGHG4

文献 (12)

Recent publications for all applications. Explore the full list and refine your search

Materials today. Bio 34:102233 PubMed40917514

2025

Engineered biomimetic vesicles induce cuproptosis and disrupt efferocytosis for metastatic adenoid cystic carcinoma immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Mingyang Li,Wenjing Dong,Yuhan Cui,Jingwen Li,Chenyu Yang,Dongsheng Zhang,Xiao Fu

Acta neuropathologica 149:55 PubMed40455292

2025

Anti-pyroglutamate-3 Aβ immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Aβ amyloidosis.

Applications

Unspecified application

Species

Unspecified reactive species

Fan Liao,Maria Calvo-Rodriguez,Meha Chhaya,Julian P Sefrin,Erik I Charych,Mario Mezler,Diana Clausznitzer,Emily J McGlame,Karen Zhao,Allison Rodgers,Yang Cao,Philipp F Secker,Laura Fernandez Garcia-Agudo,Lili Huang,Corinna Klein,Tammy Dellovade,Eric Karran

Frontiers in pharmacology 15:1464852 PubMed39744125

2025

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Li,Shimin Chen,Yuanyuan Shi,Yuanjing Wang,Xuanzhe Wang,Qian Lin,Chao Wu,Wenshuo Fang,Peng Sun,Leina Ma

Molecular therapy : the journal of the American Society of Gene Therapy 32:3729-3742 PubMed39228125

2024

Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding.

Applications

Unspecified application

Species

Unspecified reactive species

Na Li,Nanxin Gong,Baoxin Duan,Yongyan Zhang,Yi Jian,Yanqin Xu,Jinming Liu,Xiaoqian Wang,Xiaoqi Zhang,Mingjuan Du,Feilong Zhou,Jiliang Zhao,Xiangchen Guan,Xiangda Peng,Sheng Wang,Hongkai Zhang,Xin Li

Journal of orthopaedic translation 45:211-225 PubMed38586591

2024

IRF1 governs the expression of SMARCC1 via the GCN5-SETD2 axis and actively engages in the advancement of osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Wang,Yujun Zhang,Liangping Zhang,Du He,Lan Zhao,Zhimin Miao,Wei Cheng,Chengyue Zhu,Li Zhu,Wei Zhang,Hongting Jin,Hang Zhu,Hao Pan

Experimental and therapeutic medicine 23:277 PubMed35317443

2022

Monomeric C-reactive protein level is associated with osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Yulin Liang,Ke Xu,Wenguang Liu,Xiaoling Liu,Ping Yuan,Peng Xu,Haiyun Li

International journal of biological macromolecules 195:609-619 PubMed34871658

2021

Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Pan Wang,Peiyang Ding,Qiang Wei,Hongliang Liu,Yunchao Liu,Qingmei Li,Yunrui Xing,Ge Li,Enmin Zhou,Gaiping Zhang

Bioengineered 12:11138-11155 PubMed34783292

2021

DNA methyltransferase 3 beta mediates the methylation of the microRNA-34a promoter and enhances chondrocyte viability in osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Shouliang Xiong,Yong Zhao,Tiantong Xu

Biochemical and biophysical research communications 571:152-158 PubMed34325131

2021

A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.

Applications

Unspecified application

Species

Unspecified reactive species

Yingyi Long,Shuyi Song,Feiyang Luo,Xiaojian Han,Chao Hu,Yingming Wang,Shenglong Li,Wang Wang,Huajun Zhang,Bo Zhang,Tingting Li,Aishun Jin

Cancer research 81:3402-3414 PubMed33687950

2021

Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Darren C Phillips,Fritz G Buchanan,Dong Cheng,Larry R Solomon,Yu Xiao,John Xue,Stephen K Tahir,Morey L Smith,Haichao Zhang,Deborah Widomski,Vivek C Abraham,Nan Xu,Zhihong Liu,Li Zhou,Enrico DiGiammarino,Xin Lu,Nandini Rudra-Ganguly,Bruce Trela,Susan E Morgan-Lappe
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com